Swiss National Bank Sells 5,200 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Swiss National Bank trimmed its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 2.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 182,300 shares of the company’s stock after selling 5,200 shares during the period. Swiss National Bank owned about 0.31% of Molina Healthcare worth $65,867,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in MOH. Desjardins Global Asset Management Inc. lifted its stake in Molina Healthcare by 4.4% in the 4th quarter. Desjardins Global Asset Management Inc. now owns 763 shares of the company’s stock worth $276,000 after purchasing an additional 32 shares in the last quarter. Ritholtz Wealth Management lifted its position in shares of Molina Healthcare by 2.1% in the fourth quarter. Ritholtz Wealth Management now owns 1,620 shares of the company’s stock worth $585,000 after buying an additional 33 shares in the last quarter. New York Life Investment Management LLC boosted its stake in Molina Healthcare by 0.4% during the third quarter. New York Life Investment Management LLC now owns 8,495 shares of the company’s stock valued at $2,785,000 after buying an additional 36 shares during the last quarter. Aptus Capital Advisors LLC grew its holdings in Molina Healthcare by 5.0% during the 3rd quarter. Aptus Capital Advisors LLC now owns 763 shares of the company’s stock valued at $250,000 after buying an additional 36 shares in the last quarter. Finally, Raleigh Capital Management Inc. increased its stake in Molina Healthcare by 40.4% in the 3rd quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after acquiring an additional 36 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 711 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the transaction, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock valued at $6,472,517 in the last three months. Company insiders own 1.11% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on MOH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. TD Cowen dropped their price objective on shares of Molina Healthcare from $453.00 to $412.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. StockNews.com cut shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 8th. Truist Financial increased their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a report on Tuesday, February 20th. Finally, Wells Fargo & Company reduced their price objective on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating on the stock in a research note on Monday, April 29th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $398.55.

Molina Healthcare Trading Up 0.0 %

MOH opened at $339.68 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49. The stock’s 50 day moving average price is $384.15 and its 200-day moving average price is $371.92. Molina Healthcare, Inc. has a one year low of $266.35 and a one year high of $423.92. The stock has a market cap of $19.91 billion, a price-to-earnings ratio of 18.43, a P/E/G ratio of 1.04 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping the consensus estimate of $5.46 by $0.27. The business had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period last year, the company earned $5.81 earnings per share. On average, equities analysts forecast that Molina Healthcare, Inc. will post 23.59 EPS for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.